(Q39385088)

11 September 2017

title

Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents (English)

1 reference

11 September 2017

9

Cristina Marzano

1 reference

11 September 2017

8

Valentina Gandin

1 reference

11 September 2017

5

Maria Pia Rigobello

1 reference

11 September 2017

6

Anna Citta

1 reference

11 September 2017

7

Alessandro Dolmella

1 reference

11 September 2017

1

Rossana Galassi

1 reference

11 September 2017

2

Alfredo Burini

1 reference

11 September 2017

4

Maura Pellei

1 reference

11 September 2017

Simone Ricci

3

1 reference

11 September 2017

language of work or name

English

0 references

publication date

5 March 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

41

1 reference

11 September 2017

issue

17

1 reference

11 September 2017

page(s)

5307-5318

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

11 September 2017

1 reference

Cholic acid-carboplatin compounds (CarboChAPt) as models for specific drug delivery: synthesis of novel carboplatin analogous derivatives and comparison of the cytotoxic properties with corresponding cisplatin compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Non platinum metal complexes as anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Novel gold(I) 7-azacoumarin complex: synthesis, structure, optical properties, and cytotoxic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Antitumor activity of gold(i), silver(i) and copper(i) complexes containing chiral tertiary phosphines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

The anti-tumour properties and biodistribution (as determined by the radiolabeled equivalent) of Au-compounds intended as potential chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Synthesis, structural characterization and in vitro cytotoxicity of new Au(III) and Au(I) complexes with thioamides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Pyrazoles and pyrazolides-flexible synthons in self-assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Supramolecular assembly of trimeric gold(I) pyrazolates through aurophilic attractions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Gold(I) chloride adducts of 1,3-bis(di-2-pyridylphosphino)propane: synthesis, structural studies and antitumour activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Targeting selenium metabolism and selenoproteins: novel avenues for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Silver and gold luminescent metallomesogens based on pyrazole ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Mercury CSD 2.0– new features for the visualization and investigation of crystal structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

The Cambridge Structural Database: a quarter of a million crystal structures and rising

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Triazole-Au(I) complexes: a new class of catalysts with improved thermal stability and reactivity for intermolecular alkyne hydroamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Silencing MRP4 by small interfering RNA reverses acquired DDP resistance of gastric cancer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Detailed study of the different taurine uptake systems of colon LoVo MDR and non-MDR cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Structure analysis and molecular model of the selenoenzyme glutathione peroxidase at 2.8 Å resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Phase annealing in SHELX-90: direct methods for larger structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

21 January 2018

A short history of SHELX

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Treatment of lung cancer cells with cytotoxic levels of sodium selenite: effects on the thioredoxin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

SIR97: a new tool for crystal structure determination and refinement

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

OLEX2: a complete structure solution, refinement and analysis program

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Dinuclear gold(III) pyrazolato complexes – Synthesis, structural characterization and transformation to their trinuclear gold(I) and gold(I/III) analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2DT11781A

21 January 2018

Identifiers

DOI

10.1039/C2DT11781A

1 reference

11 September 2017

1 reference